FIELD: medicine.
SUBSTANCE: invention refers to organic chemistry and pharmaceutics and concerns a new benzoxazole-5-(ethylsulphonyl)-2-(naphthalinyl-2-yl)benzo[d] oxazole derivative and a pharmaceutical composition for treating or preventing Duchenne muscular dystrophy or Becker muscular dystrophy.
EFFECT: high clinical effectiveness.
3 cl, 4 dwg, 1 tbl, 50 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FXIa INHIBITORS, A METHOD OF THEIR PRODUCTION AND USE IN PHARMACEUTICALS | 2020 |
|
RU2802878C1 |
| 2,4-PYRIMIDINDIAMINE COMPOUNDS HAVING EFFECT IN CASE OF AUTOIMMUNE DISORDERS | 2004 |
|
RU2356901C2 |
| PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | 2017 |
|
RU2757457C2 |
| ARYLMETHOXY ISOINDOLIN DERIVATIVE, COMPOSITIONS INCLUDING THEREOF AND METHODS OF THEIR APPLICATION | 2011 |
|
RU2567753C2 |
| HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS | 2010 |
|
RU2615130C2 |
| ARYLAMIDE DERIVATIVES AS TTX-S BLOCKERS | 2011 |
|
RU2535671C1 |
| MENIN-MLL INTERACTION INHIBITORS | 2017 |
|
RU2799820C2 |
| METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION | 2020 |
|
RU2820673C2 |
| PHOSPHOINDOLES AS HIV INHIBITORS | 2005 |
|
RU2393163C2 |
| AZOLE AND THIAZOLE DERIVATIVES AND USE THEREOF | 2006 |
|
RU2436779C2 |
